tiprankstipranks
Trending News
More News >
Astellas Pharma Inc (ALPMF)
OTHER OTC:ALPMF
US Market

Astellas Pharma (ALPMF) Ratios

Compare
54 Followers

Astellas Pharma Ratios

ALPMF's free cash flow for Q2 2026 was ¥0.74. For the 2026 fiscal year, ALPMF's free cash flow was decreased by ¥ and operating cash flow was ¥0.20. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.03 0.93 0.93 1.45 1.34
Quick Ratio
0.80 0.74 0.74 1.21 1.12
Cash Ratio
0.22 0.26 0.26 0.52 0.46
Solvency Ratio
0.17 0.09 0.09 0.22 0.23
Operating Cash Flow Ratio
0.30 0.13 0.13 0.45 0.37
Short-Term Operating Cash Flow Coverage
0.96 0.37 0.37 4.37 0.00
Net Current Asset Value
¥ -469.03B¥ -778.88B¥ -778.88B¥ 101.39B¥ 51.27B
Leverage Ratios
Debt-to-Assets Ratio
0.21 0.28 0.28 0.08 0.09
Debt-to-Equity Ratio
0.46 0.63 0.63 0.13 0.15
Debt-to-Capital Ratio
0.31 0.39 0.39 0.12 0.13
Long-Term Debt-to-Capital Ratio
0.17 0.22 0.22 0.03 0.00
Financial Leverage Ratio
2.14 2.24 2.24 1.63 1.60
Debt Service Coverage Ratio
1.22 0.39 0.39 2.47 42.08
Interest Coverage Ratio
20.58 13.30 13.30 15.15 31.46
Debt to Market Cap
0.20 0.31 0.31 0.04 0.00
Interest Debt Per Share
422.78 566.05 566.05 114.72 117.69
Net Debt to EBITDA
0.83 3.43 3.43 -0.74 -0.43
Profitability Margins
Gross Profit Margin
78.02%81.76%81.76%81.01%80.48%
EBIT Margin
17.44%2.31%2.31%9.29%12.49%
EBITDA Margin
27.10%12.18%12.18%15.83%18.60%
Operating Profit Margin
17.15%7.77%7.77%8.76%12.01%
Pretax Profit Margin
6.80%1.56%1.56%8.72%12.10%
Net Profit Margin
6.22%1.06%1.06%6.50%9.57%
Continuous Operations Profit Margin
6.20%1.06%1.06%6.42%9.54%
Net Income Per EBT
91.52%68.26%68.26%74.58%79.09%
EBT Per EBIT
39.65%20.04%20.04%99.50%100.77%
Return on Assets (ROA)
3.62%0.48%0.48%4.02%5.32%
Return on Equity (ROE)
8.19%1.07%1.07%6.55%8.50%
Return on Capital Employed (ROCE)
16.20%5.46%5.46%7.69%9.46%
Return on Invested Capital (ROIC)
12.34%3.09%3.09%5.50%7.49%
Return on Tangible Assets
6.26%1.00%1.00%6.31%8.83%
Earnings Yield
3.36%0.58%0.58%2.88%3.51%
Efficiency Ratios
Receivables Turnover
2.80 2.93 2.93 3.55 3.39
Payables Turnover
2.61 1.58 1.58 2.06 1.94
Inventory Turnover
1.42 1.18 1.18 1.65 1.65
Fixed Asset Turnover
6.01 5.46 5.46 5.30 4.82
Asset Turnover
0.58 0.45 0.45 0.62 0.56
Working Capital Turnover Ratio
17.54 13.77 13.77 5.42 5.02
Cash Conversion Cycle
247.30 204.03 204.03 146.09 139.92
Days of Sales Outstanding
130.29 124.73 124.73 102.86 107.70
Days of Inventory Outstanding
256.59 310.41 310.41 220.74 220.83
Days of Payables Outstanding
139.58 231.11 231.11 177.51 188.61
Operating Cycle
386.88 435.14 435.14 323.60 328.53
Cash Flow Ratios
Operating Cash Flow Per Share
225.11 96.18 96.18 180.09 139.18
Free Cash Flow Per Share
206.32 50.18 50.18 131.44 97.85
CapEx Per Share
18.79 46.00 46.00 48.65 41.33
Free Cash Flow to Operating Cash Flow
0.92 0.52 0.52 0.73 0.70
Dividend Paid and CapEx Coverage Ratio
2.43 0.87 0.87 1.74 1.59
Capital Expenditure Coverage Ratio
11.98 2.09 2.09 3.70 3.37
Operating Cash Flow Coverage Ratio
0.54 0.17 0.17 1.64 1.21
Operating Cash Flow to Sales Ratio
0.20 0.11 0.11 0.22 0.20
Free Cash Flow Yield
9.95%3.06%3.06%6.98%5.12%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
29.75 172.65 172.65 34.72 28.49
Price-to-Sales (P/S) Ratio
1.85 1.84 1.84 2.26 2.73
Price-to-Book (P/B) Ratio
2.30 1.84 1.84 2.27 2.42
Price-to-Free Cash Flow (P/FCF) Ratio
10.05 32.71 32.71 14.33 19.53
Price-to-Operating Cash Flow Ratio
9.21 17.06 17.06 10.46 13.73
Price-to-Earnings Growth (PEG) Ratio
0.56 -2.09 -2.09 -1.81 8.60
Price-to-Fair Value
2.30 1.84 1.84 2.27 2.42
Enterprise Value Multiple
7.66 18.49 18.49 13.52 14.24
Enterprise Value
4.17T 3.61T 3.61T 3.25T 3.43T
EV to EBITDA
7.66 18.49 18.49 13.52 14.24
EV to Sales
2.08 2.25 2.25 2.14 2.65
EV to Free Cash Flow
11.28 40.15 40.15 13.59 18.96
EV to Operating Cash Flow
10.33 20.95 20.95 9.92 13.33
Tangible Book Value Per Share
88.38 -154.20 -154.20 339.03 288.61
Shareholders’ Equity Per Share
900.22 889.98 889.98 828.54 789.48
Tax and Other Ratios
Effective Tax Rate
0.09 0.32 0.32 0.25 0.21
Revenue Per Share
1.12K 894.27 894.27 834.40 700.74
Net Income Per Share
69.72 9.50 9.50 54.24 67.08
Tax Burden
0.92 0.68 0.68 0.75 0.79
Interest Burden
0.39 0.68 0.68 0.94 0.97
Research & Development to Revenue
0.15 0.18 0.18 0.18 0.19
SG&A to Revenue
0.00 0.46 0.46 0.42 0.42
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
3.23 10.12 10.12 2.48 1.64
Currency in JPY